摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-methoxyethyl 3-methoxypropyl ether | 126621-33-8

中文名称
——
中文别名
——
英文名称
2-methoxyethyl 3-methoxypropyl ether
英文别名
1-Methoxy-3-(2-methoxyethoxy)propane
2-methoxyethyl 3-methoxypropyl ether化学式
CAS
126621-33-8
化学式
C7H16O3
mdl
——
分子量
148.202
InChiKey
URGVVHLIFKOVAH-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.1
  • 重原子数:
    10
  • 可旋转键数:
    7
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    27.7
  • 氢给体数:
    0
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为产物:
    描述:
    参考文献:
    名称:
    Thermal synthesis and pyrolysis of a xylan
    摘要:
    A xylan has been synthesized in yields up to 64% by thermal polymerization of methyl beta-D-xylopyranoside, catalyzed by phosphoric acid. The polymer is highly branched, with d.p. approximately 20. The xylose units in the polymer are predominantly pyranose, with some furanose, and 14% of the nonreducing end groups are in the furanose form. The ''reducing'' end groups are at least partly in the form of methyl xylosides. Vacuum pyrolysis of the pure synthetic xylan gave a high char yield (48%, compare, for example 5% from pure cellulose), 1,4-anhydro-alpha-D-xylopyranose (5.7%), and 1,5-anhydro-4-deoxypent-1-en-3-ulose (2.4%). The structure of the latter compound was verified by degradation experiments and it was shown to be the compound previously isolated from pyrolysis of natural xylans and incorrectly assigned as 3-hydroxy-2-penteno- 1,5-lactone. This glyculose has considerable importance as a marker compound for xylans in pyrolysis of biomass materials.
    DOI:
    10.1016/0008-6215(91)84093-t
点击查看最新优质反应信息

文献信息

  • CEREBLON LIGANDS AND BIFUNCTIONAL COMPOUNDS COMPRISING THE SAME
    申请人:Arvinas, Inc.
    公开号:US20180215731A1
    公开(公告)日:2018-08-02
    The description relates to cereblon E3 ligase binding compounds, including bifunctional compounds comprising the same, which find utility as modulators of targeted ubiquitination, especially inhibitors of a variety of polypeptides and other proteins which are degraded and/or otherwise inhibited by bifunctional compounds according to the present disclosure. In particular, the description provides compounds, which contain on one end a ligand which binds to the cereblon E3 ubiquitin ligase and on the other end a moiety which binds a target protein such that the target protein is placed in proximity to the ubiquitin ligase to effect degradation (and inhibition) of that protein. Compounds can be synthesized that exhibit a broad range of pharmacological activities consistent with the degradation/inhibition of targeted polypeptides of nearly any type.
    该描述涉及cereblon E3连接酶结合化合物,包括包含相同成分的双功能化合物,这些化合物作为靶向泛素化的调节剂具有实用价值,尤其是抑制剂,可降解和/或以其他方式抑制根据本公开的双功能化合物。特别是,该描述提供了化合物,其一端含有与cereblon E3泛素连接酶结合的配体,另一端含有与目标蛋白结合的部分,使目标蛋白位于泛素连接酶附近以降解(和抑制)该蛋白。可以合成表现出广泛药理活性的化合物,与几乎所有类型的靶向多肽的降解/抑制一致。
  • COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF RAPIDLY ACCELERATED FIBROSARCOMA POLYPEPTIDES
    申请人:Arvinas, Inc.
    公开号:US20180179183A1
    公开(公告)日:2018-06-28
    The present disclosure relates to bifunctional compounds, which find utility as modulators of Rapidly Accelerated Fibrosarcoma (RAF, such as c-RAF, A-RAF and/or B-RAF; the target protein). In particular, the present disclosure is directed to bifunctional compounds, which contain on one end a Von Hippel-Lindau, cereblon, Inhibitors of Apotosis Proteins or mouse double-minute homolog 2 ligand which binds to the respective E3 ubiquitin ligase and on the other end a moiety which binds the target protein RAF, such that the target protein is placed in proximity to the ubiquitin ligase to effect degradation (and inhibition) of target protein. The present disclosure exhibits a broad range of pharmacological activities associated with degradation/inhibition of target protein. Diseases or disorders that result from aggregation or accumulation of the target protein, or the constitutive activation of the target protein, are treated or prevented with compounds and compositions of the present disclosure.
    本公开涉及双功能化合物,其作为快速加速纤维肉瘤(RAF,如c-RAF、A-RAF和/或B-RAF;目标蛋白)的调节剂而发挥作用。具体而言,本公开涉及含有一端为Von Hippel-Lindau、cereblon、凋亡抑制蛋白或鼠双分子同源物2配体的双功能化合物,该配体与相应的E3泛素连接酶结合,并且另一端含有结合目标蛋白RAF的基团,使得目标蛋白与泛素连接酶靠近,以实现目标蛋白的降解(和抑制)。本公开展示了与目标蛋白的降解/抑制相关的广泛药理活性范围。本公开的化合物和组合物用于治疗或预防由目标蛋白的聚集或积累,或目标蛋白的构成性激活导致的疾病或紊乱。
  • COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF ENHANCER OF ZESTE HOMOLOG 2 POLYPEPTIDE
    申请人:Arvinas, Inc.
    公开号:US20180177750A1
    公开(公告)日:2018-06-28
    The present disclosure relates to bifunctional compounds, which find utility as modulators of enhancer of zeste homolog 2 (target protein). In particular, the present disclosure is directed to bifunctional compounds, which contain on one end a Von Hippel-Lindau, cereblon, Inhibitors of Apotosis Proteins or mouse double-minute homolog 2 ligand which binds to the respective E3 ubiquitin ligase and on the other end a moiety which binds the target protein, such that the target protein is placed in proximity to the ubiquitin ligase to effect degradation (and inhibition) of target protein. The present disclosure exhibits a broad range of pharmacological activities associated with degradation/inhibition of target protein. Diseases or disorders that result from aggregation or accumulation of the target protein are treated or prevented with compounds and compositions of the present disclosure.
    本公开涉及双功能化合物,其作为增强子锁定同源2的调节剂而发挥作用。具体而言,本公开涉及包含一端为Von Hippel-Lindau、cereblon、凋亡抑制蛋白或鼠双分子同源2配体的双功能化合物,该配体与相应的E3泛素连接酶结合,另一端含有结合目标蛋白的基团,使目标蛋白靠近泛素连接酶以实现目标蛋白的降解(和抑制)。本公开展示了与目标蛋白的降解/抑制相关的广泛药理活性范围。本公开的化合物和组合物用于治疗或预防由目标蛋白聚集或积累导致的疾病或紊乱。
  • Sulfonamide compound
    申请人:Matsubara Koki
    公开号:US20090048223A1
    公开(公告)日:2009-02-19
    A compound represented by the formula (1) [A represents a nitrogen-containing saturated ring; m represents an integer of 0 to 2; n represents an integer of 1 to 4; G 1 represents hydrogen atom, chlorine atom, hydroxyl group, an alkoxy group, or amino group; G 2 represents a halogen atom, hydroxyl group, cyano group, carboxy group, an alkyl group, an alkenyl group, an alkynyl group, an alkoxy group, an alkylthio group, an amino group, an alkylsulfinyl group, an alkylsulfonyl group, or an aryl group; G 3 represents hydrogen atom, a halogen atom, hydroxyl group, cyano group, carboxy group, an alkyl group, an alkenyl group, an alkynyl group, an alkoxy group, an alkylthio group, an amino group, an alkoxycarbonyl group, an acyl group, an acyloxy group, an alkylsulfinyl group, an alkylsulfonyl group, or an aryl group; Y represents a single bond, or —C(R 3 )(R 4 )— (R 3 and R 4 represent hydrogen atom, or an alkyl group, or alkylene groups which combine together to form a saturated hydrocarbon ring group); G 4 represents hydroxyl group (Y is a single group), or —N(R 1 )(R 2 ) (R 1 and R 2 represent hydrogen atom, an alkyl group, an aralkyl group, an alkenyl group, an alkynyl group, a saturated heterocyclic group, an alkylsulfonyl group, an acyl group, or an amidino group); G 5 is a substituent on a ring-constituting carbon atom of A, and represents hydrogen atom, fluorine atom, or an alkyl group] or a salt thereof, or a derivative thereof that is a prodrug, which potently inhibits Rho kinase.
    由以下化学式表示的化合物:[A代表含氮饱和环;m表示0到2的整数;n表示1到4的整数;G1代表氢原子、氯原子、羟基、烷氧基或氨基;G2代表卤原子、羟基、氰基、羧基、烷基、烯基、炔基、烷氧基、烷硫基、氨基、烷氧羰基、酰基、乙酰氧基、烷基磺基、烷基磺酰基或芳基;G3代表氢原子、卤原子、羟基、氰基、羧基、烷基、烯基、炔基、烷氧基、烷硫基、氨基、烷氧羰基、酰基、乙酰氧基、烷基磺基、烷基磺酰基或芳基;Y代表单键,或-C(R3)(R4)-(R3和R4代表氢原子、烷基或烷烯基,它们结合在一起形成饱和碳氢环基);G4代表羟基(Y是单个基),或-N(R1)(R2)(R1和R2代表氢原子、烷基、芳基、烯基、炔基、饱和杂环基、烷基磺酰基、酰基或胺基);G5是A的环构成碳原子上的取代基,代表氢原子、氟原子或烷基]或其盐、或作为前药的衍生物,其强力抑制Rho激酶。
  • METHOD FOR PRODUCING CARBONATE COMPOUND
    申请人:Asahi Glass Company, Limited
    公开号:US20150284314A1
    公开(公告)日:2015-10-08
    The present invention relates to a production process capable of selectively producing various kinds of carbonate compounds without restraint in high yields without using toxic compounds such as phosgene and crown ethers, without producing corrosive gases such as hydrogen chloride as a by-product, and without necessity of removing the chloroform as a by-product by distillation, and to a method for producing a carbonate compound, containing reacting compound (1) with a compound having an OH group in the presence of a metal salt and 0.2 to 4.0 mol of compound (2) per mol of the metal salt to obtain a carbonate compound, in which m is an integer of 1-10, Q is an alkylene group having 1 to 4 carbon atoms, etc, and R 10 and R 11 are alkyl groups having 1 to 5 carbon atoms, etc.
    本发明涉及一种生产过程,能够在高产率下有选择地生产各种碳酸盐化合物,而不使用像光气和冠醚这样的有毒化合物,也不产生像氯化氢这样的腐蚀性气体作为副产品,也不需要通过蒸馏去除氯仿作为副产品,以及一种制备碳酸盐化合物的方法,其中包括在金属盐和化合物(1)的存在下,将化合物(1)与具有羟基的化合物反应,每摩尔金属盐添加0.2到4.0摩尔的化合物(2),以获得碳酸盐化合物,其中m是1-10的整数,Q是具有1到4个碳原子的烷基基团,R10和R11是具有1到5个碳原子的烷基基团等。
查看更多